CLINICAL EFFICACY OF LEFLUNOMIDE/HYDROXYCHLOROQUINE COMBINATION THERAPY IN PRIMARY SJOGREN'S SYNDROME IS PREDICTED BY SERUM PROTEOME BIOMARKERS - RESULTS FROM REPURPSS-I
Publication date
2019-06
Authors
van Roon, Joel A.G.
van der Heijden, Eefje Hm
Blokland, S L M
Lopes, Ana P
Moret, Frederique M.
Welsing, PMJ
Janssen, Nard G.
Rosenberg, Toine
Pandit, Aridaman
Tao, Weiyang
Editors
Advisors
Supervisors
Document Type
Abstract
Metadata
Show full item recordCollections
License
Abstract
Keywords
Citation
Van Roon, J, van der Heijden, E, Blokland, S, Lopes, A, Moret, F, Welsing, P, Janssen, N, Rosenberg, T, Pandit, A, Tao, W, Hillen, M, Kruize, A A & Radstake, T R 2019, 'CLINICAL EFFICACY OF LEFLUNOMIDE/HYDROXYCHLOROQUINE COMBINATION THERAPY IN PRIMARY SJOGREN'S SYNDROME IS PREDICTED BY SERUM PROTEOME BIOMARKERS - RESULTS FROM REPURPSS-I', Annals of the Rheumatic Diseases, vol. 78, no. Suppl 2, pp. 396-396. https://doi.org/10.1136/annrheumdis-2019-eular.5681